Churchhouse AMD, Billard CV, Suzuki T, Pohl SOG, et al. Loss of DOCK2 potentiates Inflammatory Bowel Disease-associated colorectal cancer via immune dysfunction and IFNgamma induction of IDO1 expression. Oncogene 2024 Sep 7. doi: 10.1038/s41388-024-03135.
PMID: 39242821